- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Azacitidine plus Deferasirox
Total 5699 results
-
The Hospital for Sick ChildrenCompletedChildhood Solid Tumor | Recurrent Childhood CNS Tumor | Ependymoma, Recurrent ChildhoodUnited States, Canada, Australia
-
The University of Texas Health Science Center,...CompletedBrain Tumor RecurrentUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.RecruitingRecurrent Chronic Myelomonocytic Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic Syndrome | Therapy-Related Myelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterRecruitingAcute Myeloid Leukemia | Therapy-Related Acute Myeloid Leukemia | Acute Bilineal Leukemia | Acute Biphenotypic Leukemia | T Acute Lymphoblastic Leukemia | Mixed Phenotype Acute LeukemiaUnited States
-
Novartis PharmaceuticalsCompletedTransfusional HemosiderosisUnited States
-
Novartis PharmaceuticalsCompletedIron Overload | Hereditary HemochromatosisUnited States, Germany, Italy, Australia, Canada, France
-
Academisch Medisch Centrum - Universiteit van Amsterdam...CompletedSickle Cell DiseaseNetherlands
-
Abramson Cancer Center of the University of PennsylvaniaCompletedHigh Risk MDS or AML PatientsUnited States
-
Novartis PharmaceuticalsCompletedMyelodysplastic Syndromes | Transfusion Dependent Iron OverloadGermany
-
NovartisCompletedMyelodysplastic Syndromes | Hemoglobinopathies | Diamond-Blackfan Anemia | Transfusional Iron Overload | Other Inherited or Acquired Anaemia | MPD Syndrome | Other Rare AnaemiasAustralia
-
Masonic Cancer Center, University of MinnesotaTerminatedLymphoma | Myelodysplastic Syndromes | Leukemia | Breast Cancer | Iron Overload | Ovarian Cancer | Neuroblastoma | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Novartis PharmaceuticalsCompletedMyelodysplastic Syndromes | Beta-ThalassemiaHungary
-
Novartis PharmaceuticalsCompletedTransfusional Hemosiderosis | Transfusional Iron OverloadTaiwan, Turkey, Egypt, United Kingdom, Thailand, Canada, China, Italy, Cyprus, Lebanon, United Arab Emirates
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMyelodysplastic Syndrome | High Risk Myelodysplastic Syndrome | IPSS Risk Category Intermediate-1United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.RecruitingAcute Myeloid Leukemia | Therapy-Related Acute Myeloid Leukemia | Hematologic and Lymphocytic Disorder | Acute Myeloid Leukemia in Remission | FLT3 Gene Mutation | Minimal Residual Disease PersistenceUnited States
-
Elliott VichinskyCompletedIron Overload | ThalassemiaUnited States
-
Novartis PharmaceuticalsCompletedTransfusional Hemosiderosis | Chronic AnemiaJapan, Turkey, Spain, Poland, Singapore
-
Novartis PharmaceuticalsCompletedNon-transfusion Dependent ThalassemiaGreece, Taiwan, Italy, United Kingdom, Lebanon, Turkey, Malaysia, Thailand, United States
-
University of OklahomaCelgene CorporationTerminatedPancreatic CancerUnited States
-
SymBio PharmaceuticalsWithdrawnMyelodysplastic SyndromeJapan
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterTerminatedLeukemiaUnited States
-
Children's Hospital Los AngelesNovartis PharmaceuticalsTerminatedAnemia, Sickle Cell | Transfusion HemosiderosisUnited States
-
Novartis PharmaceuticalsCompletedTransfusional HemosiderosisEgypt, Spain, United Kingdom, Jordan
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnStage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer
-
M.D. Anderson Cancer CenterCelgene CorporationCompletedLeukemiaUnited States
-
Novartis PharmaceuticalsCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); CelgeneRecruitingAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome With Excess Blasts | IDH2 Gene Mutation | Recurrent High Risk Myelodysplastic Syndrome | Refractory High Risk Myelodysplastic Syndrome | Blasts 20-30 Percent of Bone Marrow Nucleated CellsUnited States
-
National Cancer Institute (NCI)WithdrawnRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingChronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Recurrent Myelodysplastic Syndrome | Refractory Myelodysplastic Syndrome | Therapy-Related Myelodysplastic SyndromeUnited States
-
Universitätsklinikum Hamburg-EppendorfCompletedChronic Myelomonocytic Leukemia | Myelodysplastic SyndromeGermany
-
National Institute of Diabetes and Digestive and...Completed
-
Novartis PharmaceuticalsCompleted
-
New Mexico Cancer Care AllianceCompletedAdvanced Solid Tumor MalignanciesUnited States
-
Technische Universität DresdenAbbVie; University Hospital HeidelbergNot yet recruitingAcute Myeloid LeukemiaGermany
-
National Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Leukemia | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Myelodysplastic Syndrome | Secondary Myelodysplastic Syndrome | de Novo Myelodysplastic SyndromeUnited States
-
Carlos Graux, MD, PhDCelgene Corporation; Belgian Hematological SocietyCompletedMyelodysplastic Syndrome | Acute Myelogenous LeukemiaBelgium
-
Celyad Oncology SAWithdrawnMyelodysplastic Syndromes | AML, Adult
-
University of PisaIRCCS Burlo Garofolo; University of GenovaRecruiting
-
Children's Hospital of PhiladelphiaAnn & Robert H Lurie Children's Hospital of Chicago; The Cooley's Anemia Foundation...CompletedThalassemia Major With Severe Transfusional Iron OverloadUnited States
-
Novartis PharmaceuticalsCompletedIron Overload | Sickle Cell Disease | Hemolytic AnemiaUnited States, Canada
-
Hormozgan University of Medical SciencesCompletedIron Overload | Thalassemia | Transfusion Related ComplicationsIran, Islamic Republic of
-
Novartis PharmaceuticalsCompletedHereditary HemochromatosisBelgium, France, Russian Federation, Romania, Slovakia, Spain, Switzerland
-
Seoul National University HospitalNot yet recruitingDiffuse Large B Cell Lymphoma | Refractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin LymphomaKorea, Republic of
-
M.D. Anderson Cancer CenterRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Hematopoietic and Lymphoid System Neoplasm | Myeloproliferative NeoplasmUnited States
-
M.D. Anderson Cancer CenterHiberCell, Inc.RecruitingAcute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterBayerCompleted
-
M.D. Anderson Cancer CenterAriad PharmaceuticalsWithdrawnLeukemia | FLT3-Mutated Acute Myeloid Leukemia | FLT3-Mutated High-Risk Myelodysplastic Syndrome
-
M.D. Anderson Cancer CenterCelgeneCompleted